Vitamin D and bone health
Phase 2
- Registration Number
- CTRI/2022/07/044030
- Lead Sponsor
- Department of Biotechnology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Apparently healthy subjects with serum 25(OH)D less than 20 ng/ml, TBS less than 1.310.
Exclusion Criteria
More than 60 years, less than 20 years of age, serum 25(OH) more than 20 ng/ml.
Subjects with co morbid condition like history of use of antitubercular, antiepileptic drugs or indigenous medicine for more than three months during past six months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in trabecular bone score with cholecalciferol and Calcium supplementationTimepoint: Trabecular bone score will be measured at baseline, <br/ ><br>at 6 months and 12 months after cholecalciferol and Calcium supplementation
- Secondary Outcome Measures
Name Time Method Trend in BMDTimepoint: At six months and one year.